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ABSTRACT 
 Marginal structural models (MSMs) with inverse probability of treatment weighting (IPTW) are 
commonly used to estimate causal effects in longitudinal observational studies. They have been shown 
to provide more accurate estimates than traditional methods in the presence of time-varying 
confounders that are affected by previous treatment. However, the treatment of missing data in these 
studies is challenging because of the multilevel structure of the data and the way the weights are 
compounded in the MSM with IPTW framework. 
 This project applied several methods of handling missing data in MSMs with IPTW to a study of 
asthmatic children at the Kunsberg School at National Jewish Health where the data were collected 
intermittently. Methods included multiple imputation on the data; filling in the missing weights with the 
last value carried forward (LVCF); filling in the weights by restarting them at one each time there is a 
missing value; and four different ways of filling in gaps in the individual probabilities used to create the 
weights: (1) average value by subject, (2) average of the two probabilities on either side of the gap, (3) 
linear interpolation, and (4) the average of randomly generated values. The estimate of interest was the 
effect of medication use on FEV1 after adjusting for time-varying effects of asthma symptoms. The 
performance of the different methods was compared using a simulation study. 
The simulation results suggested that filling in the weights by restarting them at one at each gap 
is the most appropriate of those tested for the Kunsberg data. When this method was applied to the 
Kunsberg data, we obtained an estimate of 0.076 (95% CI: -0.020, 0.171) for the effect of medication use 
on FEV1. This effect was not statistically significant. 
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Observational data are a key source of insight into medical and biological questions when 
randomization is difficult or unethical. However, analysis of this kind of data presents special challenges, 
especially when repeated measures are taken over time. Longitudinal observational studies often 
feature time-varying covariates; these can be exposures, confounders, or outcomes whose values 
change over time. Time-varying confounders are variables that are predictors of both the outcome of 
interest and subsequent exposure. In some cases these confounders are also affected by previous 
treatment1. For example, in a study of the effect of exercise on osteoarthritis outcomes, current knee 
pain is a time-varying confounder that both affects subsequent exercise and is affected by previous 
exercise2. When a time-varying confounder is affected by previous treatment, standard approaches for 
adjustment of confounding have been shown to be biased1, 3, 4. Marginal structural models (MSMs) are a 
class of causal models developed by Robins, Hernan, and Brumback1 to address this problem.  
This project will present an application of a repeated measures MSM to a longitudinal 
observational dataset with a time-varying treatment, a time-varying outcome, and a time-varying 
confounder that were collected intermittently. It will build upon previous work on this dataset 
conducted by Lu5. Specifically, it will focus on a comparison of different methods for handling 
intermittent data in marginal structural models. Methods fall into one of two broad categories: (1) 
imputation of the individual probabilities or the stabilized weights, or (2) imputation of the data. 








BASIC THEORY & METHODS 
Notation 
Notation will follow that set forth in Daniel et. al. A longitudinal setting is one in which n 
subjects (i = 1,…,n) enter a study at time 0 and are subsequently followed until the end of the study 
period at time t (t = 1,…,T). The exposure or treatment of interest is represented by A, where At,i is the 
treatment for subject i at time t. Covariates of interest are labeled L, with Lt,i being covariate value(s) for 
subject i at time t. It is assumed that values for Ai and Li remain unchanged during the interval between 
time t and time t+1. The treatment history of subject i is denoted 𝐴t,i = (A0,i,…,At,i), and the covariate 
history of subject i is denoted 𝐿t,i = (L0,i,…,Lt,i). Depending on the study structure and the question of 
interest, observed outcomes Yi can either be measured once at the end of the study or at each time 
point, with Yt,i being the outcome for subject i at time t. Capital letters represent random variables, and 
lower-case letters represent realizations of random variables. 
Potential Outcomes and Causal Effects 
 An ideal study of the effect of treatment A on outcome Y would compare an individual’s 
outcome given a certain treatment with the outcome that would have been seen for that same 
individual if, counter to fact, s/he had been given a different treatment. This unseen outcome is referred 
to as potential or counterfactual. Randomized controlled trials attempt to imitate this type of study by 
comparing groups that are identical in every way except for their treatment status.  Observational 
studies cannot do the same because treatment status is not assigned. Instead, causal models for 
observational data rely on a set of assumptions to make inference. The four major assumptions - 
ignorability, positivity, consistency, and stable unit treatment value - are discussed below. The potential 
outcome that would have been observed if subject i had received treatment history 𝑎 is denoted Yti(𝑎). 
When all assumptions are met the distribution of Y(𝑎) in the population for every realization of 
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treatment history gives the causal effect of treatment history 𝐴 on outcome Y. The aspect of the 
distribution of Y(𝑎) that is of interest depends on the outcome and the data structure. For this project 
we are interested in the mean, E[Y(𝑎)]. 
Time-dependent Confounding 
 Time-dependent confounding exists when two conditions are met: (1) each At,i is causally 
influenced by treatment at the previous time, At-1,i,  and covariates at the current time, Lt,i; and (2) each 
Yt,i is causally influenced by both treatment history and covariate history up to time t. In a subset of 
cases involving time-dependent confounding, the confounder Lt,i is also causally influenced by previous 
treatment At-1,i. The confounder is then also on the causal pathway between the treatment and the 
outcome. Figure II.1 illustrates this type of time-dependent confounding. When this type of time-
dependent confounding exists, standard regression methods that control for L can be biased and a 
marginal structural model is often a more appropriate approach. 
 
 
Figure II.1: Directed acyclic graph of the relationship between L, A, and Y 
 
Marginal Structural Models 
Marginal structural models were designed to address the bias created when standard 
approaches to confounder adjustment are applied to data with time-varying covariates. The classical 
MSM considers treatment and confounders that vary over time and a single outcome at the end of the 
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study period, and thus is defined as a model for the population mean of the counterfactual outcome 
under treatment history 𝐴, 
E[Y(𝑎)] = g((𝑎); γ), 
where g is a user-defined function and the γ parameters are the causal effect of treatment history on 
the outcome6. Repeated measures MSMs model the mean counterfactual outcome at each time point t 
+ 1 as a function of treatment history up to time t,  
E[Y(𝑎(𝑡 + 1))] = g((𝑎(t)); γ)6. 
Both time-invariant and time-varying covariates can be included in the model. There are three ways of 
estimating coefficients in MSMs: g-computation, double robust estimator, and inverse probability of 
treatment weighting (IPTW). The IPTW method will be used for this project, as it is relatively easy to 
apply and interpret5. 
A marginal structural model using IPTW estimation is a multi-step procedure. Step 1 involves the 
estimation of weights based on inverse probability of treatment. For a binary treatment, two logistic 
models are fit: one with treatment as the outcome and time-invariant covariates V as predictors, along 
with treatment history:  
logit P(At = 1|V, 𝐴t) = α0t + α1tV + α2t𝐴t, 
and another with treatment as the outcome and both time-invariant covariates and time-
varying confounders as predictors, along with treatment history:  
logit P(At = 1|V, 𝐴t, 𝐿t) = α’0t + α’1tV + α’2t𝐴t + α’3t𝐿t. 
Individual probabilities from these models are then used to create the numerator and 
denominator of the stabilized weight at each time point for each subject. The numerator of the 
stabilized weight is the conditional probability of receiving the observed treatment given time-invariant 
confounders, and the denominator is the conditional probability of receiving the observed treatment 
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given both time-invariant and time-varying confounders7. The weights are compounded at each time 
point:  
swt,i = ∏ P(At = 1|V,𝐴t)P(At = 1|V,𝐴t,𝐿t)𝑡−11 . 
The unstabilized version of the weights uses the same denominator as above with a numerator of 1. The 
unstabilized weights can be used in place of stabilized weights, but they generally provide less efficient 
estimates1. 
Step 2 fits a weighted repeated measures model of the outcome of interest on treatment. The 
weighting creates a pseudo-population with balance in all covariates. Time-varying confounders are not 
included, because they have been accounted for in the weights. Time-invariant covariates may be 
included.  
Several assumptions are made when fitting a marginal structural model. The Stable Unit 
Treatment Value Assumption (SUTVA) states both that there is only one version of each treatment and 
that the treatment assigned to one subject does not affect the potential outcomes for another subject. 
The positivity assumption states that no covariate can predict treatment status perfectly, i.e. for 
subjects with each combination of covariates, the probability of treatment is neither zero nor one. The 
Sequential Ignorability Assumption states that treatment assignment at each time point is independent 
of future potential outcomes given past observed treatment history, outcome history, and covariates. 
The consistency assumption states that the potential outcome under each realization of the treatment 
history equals the observed outcome for that particular treatment history. It is also assumed there is no 
misclassification bias and no unmeasured confounding. 
Missing Data & Marginal Structural Models 
In any longitudinal study with missing data, care must be taken to choose an appropriate 
method for handling the missingness. Though it is common for researchers to employ complete case or 
available case methods in which patients or records with missing data are simply excluded, this 
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approach may lead to biased estimates or loss of precision8. MSMs using IPTW present an additional 
challenge: because the weights are compounded at each time point, missing data at one time point may 
affect the values of the weights at all subsequent time points. 
Some simulation studies have been conducted to compare methods for addressing missing data 
in marginal structural models. Moodie et. al.9 compared multiple imputation (MI) and inverse probability 
of missingness weighting (IPMW). They recommend MI over IPMW, especially when missing data are 
strongly predicted by available data. However, they only considered up to 50% missingness in a single 
time-varying confounder, and their outcome was a single event at the end of the study. Shortreed and 
Forbes10 concluded that complete case (CC) analysis showed least bias, but they considered up to 32% 
missingness only in the exposure. Vourli and Touloumi11 compared last observation carried forward 
(LOCF), MI, and IPMW. They recommend IPMW over MI, especially when missing data are strongly 
predicted by available data. They considered up to 83% missingness, but their missing data were only in 
a single time-varying confounder and their outcome was a single event at the end of the study. Liu et. 
al.7 compared CC, MI, and IPMW. They concluded that MI produced the least biased estimates, but they 
only considered up to 30% missingness in a time-varying confounder and/or a time-invariant 
confounder. 
Two of the above studies recommend multiple imputation as the best way of handling missing 
data; however, there are some important limitations. Each simulation only considered missingness in a 
confounder or in the treatment; most of the studies only considered up to 50% missingness; and none of 
the simulations included a time-varying outcome. For these reasons, it is unclear how the different 







APPLICATION OF A MARGINAL STRUCTURAL MODEL 
Study Background 
The data for this project are drawn from a multi-year study of asthmatic students attending the 
Kunsberg School at National Jewish Health. Data were collected on students’ medication use, lung 
function, asthma symptoms, and environmental exposures. This project focuses on the data from the 
fifth year of the study, a period of 199 days from October 15th, 2003 to April 30th, 2004. During this 
school year the study subjects were 43 children with physician diagnosed asthma ranging in age from six 
to fourteen years. Sixty percent of the subjects were male and 70% were African American. The data 
structure is one commonly seen in observational studies: there are multiple measurements taken over 
time, the data collection is intermittent, and many measurements are missing. 
Table III.1: Demographics 
n 43 
sex = male (%)     26 (60.5)  
race = black (%)     30 (69.8)  
age in years (mean (SD))  10.23 (2.10) 
height in cm (mean (SD)) 138.60 (13.19) 
 
Table III.2: Uncollected data points 
  No. measurements Percent “missing” 
Overall 8557      
fev1_am (mean (SD)) 3542 58.6 
basthma1 (mean (SD)) 966 88.7 
bdoser1 (mean (SD)) 5866 31.4 
 
Question of Interest 
This project proposes to answer the question: “Does rescue medication (albuterol) use lead to 
increased lung function (FEV1) in the Kunsberg School asthmatics after accounting for asthma 
symptoms?”.  The variables of interest include a time-varying treatment (rescue medication use); a 
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time-varying outcome (lung function); baseline measures for subjects’ sex, race, age, and height; and a 
time-varying confounder (asthma symptoms).  Data for the medication use variable were collected each 
school day (Monday through Friday). Medication use was recorded as the number of times each day a 
subject used his or her rescue inhaler. Each inhaler included an electronic doser that counted each use. 
The inhalers were used primarily on an as-needed basis and as such are considered a reflection of a 
subject’s asthma symptoms5.  Doser counts were binarized into a yes/no indicator for any medication 
use for each subject on each day. Data for the asthma variable were collected intermittently in blocks of 
eight school days in a row. Asthma symptoms were self-reported on a five-point scale that was later 
binarized. An entry of zero indicates “I did not cough or wheeze last night” or “I coughed and wheezed a 
little but slept well”. An entry of one indicates “I coughed and wheezed and it woke me at least once in 
the night or it woke me early”. We hypothesize that the asthma symptoms variable is a time-varying 
covariate that is both affected by prior medication use and affects future medication use, and over time 
is both a confounder and a mediator with respect to the relationship between medication use and lung 
function.  
Previous literature suggests there is an estimated 5-10 percent improvement in pulmonary 
function of asthmatic children after rescue medication use12. Mortimer et. al. applied a marginal 
structural model to data from the Fresno Asthmatic Children’s Environment Study. The authors 
estimated that rescue medication use was causally related to a 7% increase in pulmonary function when 
medication use and function were measured on the same day12. 
The Models 
 The models for the stabilized weights are logistic models with doser as the outcome: 




logit P(dosert-1 = 1|V,  𝑑𝑜𝑠𝑒𝑟t-2) = α0t + α1tage + α2theight + α3trace + α4tsex + α5tdatet-1 + α6tfridayt-1 + 
α7t𝑑𝑜𝑠𝑒𝑟t-2, + α8tasthmat-1 
The final weighted model is a linear mixed model of the form: 
FEV1t = α0t + α1tage + α2theight + α3trace + α4tsex + α5tdatet-1 + α6tfridayt-1 + α7tdosert-1 + α8t𝑑𝑜𝑠𝑒𝑟t-2  
with a variance components structure for the R matrix. Empirical standard errors that are robust to 
misspecification of the correlation structure were used to generate p-values and 95% confidence 
intervals. 
The outcome measure, FEV1, was collected in the mornings. Because we wanted to ensure that 
the treatment, doser, preceded the outcome, a variable for doser lagged one day was used as a 
predictor instead of the same day’s doser measurement. Similarly, to ensure the value for the time-
dependent confounder, asthma symptoms, preceded both the treatment and the outcome, a variable 
for asthma symptoms lagged one day was used. This approach guaranteed that the three time-varying 
covariates occurred in an order that made sense causally. However, allowing the treatment and 
outcome to occur one day apart may result in a weaker estimate of the effect of interest that we would 
have seen if they were measured on the same day. 
The models for this project incorporate treatment history in the form of several additional 
lagged treatment variables. The number of previous treatment days was determined via a series of 
logistic regression models with treatment as the outcome. Lagged treatment variables were added to 
the model sequentially until they were no longer statistically significant predictors of treatment. Doser 
measurements lagged two days and three days were both significant predictors of treatment; doser 
lagged four days was not. Therefore, variables for doser lagged two days and three days were included 
in the weights models and the outcome model. 
In a 2008 master’s thesis by Lu5, the author discusses an application of a marginal structural 
model to the Kunsberg data. The gaps in the weights created by the intermittent data were filled using a 
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last value carried forward (LVCF) approach: during the compounding of the weights, each time an 
individual probability was missing, the most recent value for the weight was carried forward and  
compounding continued. Using this approach, Lu shows that a repeated measures MSM produces 
estimates that differ from those produced by a standard linear mixed model that adjusts for the time-
varying confounder. This project uses the LVCF approach developed by Lu as a starting point, and 
compares different methods of managing the missingness in the weights caused by intermittent 
collection in this data. 
Missing Data Methods 
Imputation of Individual Probabilities and Weights 
The Kunsberg data were intentionally collected intermittently, so most of the ‘missing’ values 
are not missing in the strict sense. Because of this, it is reasonable to assume the missingness in the data 
is ignorable. In this case, the best approach may be to use the available case data and fill in any gaps in 
the weights. These methods are ways of filling in the gaps without requiring any imputation of the data. 
They present alternatives to the LVCF approach presented in Lu. 
Available case data was fit within the MSM with IPTW framework to create stabilized probability 
of treatment weights as described above. Missing weights caused by missingness in the data were filled 
in using various methods. The final model was a weighted generalized linear mixed model (GLMM) with 
FEV1 as the outcome, medication use as the treatment, treatment history, and baseline covariates for 
race, sex, age, and height. Methods used to fill in the weights included last value carried forward (LVCF) 
and restarting the weights at one each time there is a gap. Alternatively, gaps in the individual 
probabilities were filled using (1) average value by subject, (2) average of the two probabilities on either 
side of the gap, (3) linear interpolation, and (4) the average of randomly generated values. These filled 
individual probabilities were then used to create the weights. Each method used to fill in the IP 
produced extreme weight values, and weights greater than 100 were truncated. 
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Multiple Imputation of Data 
Multiple imputation (MI) is a method used for filling in missing data that is widely used in 
longitudinal studies. It consists of three general steps: First, generate multiple copies of a dataset with 
missing values imputed using an appropriate model incorporating random variation. Second, analyze 
each completed dataset separately using a model appropriate to the question of interest. Finally, 
combine the resulting estimates and standard errors according to Rubin’s rules8. There are two general 
approaches to multiple imputation: joint modelling (JM) and fully conditional specification (FCS). FCS is a 
more flexible approach that uses univariate conditional distributions for each incomplete variable, 
allowing for a different imputation model to be selected for each variable. This is the approach that was 
used for this project. 
Imputations were performed in SAS v. 9.4 using PROC MI with an FCS statement for each 
variable to be imputed. This procedure imputes variables with missing data sequentially in an order 
specified by the user. First the binary asthma symptoms variable was imputed using a logistic regression 
model: 
logit P(asthma = 1|covariates) = β0 + β1age + β2height + β3race + β4sex. 
Then the doser (medication use) variable was imputed using a logistic regression model that included 
the imputed asthma variable: 
logit P(doser = 1|covariates) = β’0 + β’1age + β’2height + β’3race + β’4sex + β’5asthma. 
Finally the FEV1 (lung function) variable was imputed using a linear regression model that incorporated 
both the imputed asthma and doser variables: 
E[FEV1|covariates] = β’’0 + β’’1age + β’’2height + β’’3race + β’’4sex + β’’5asthma + β’’6doser. 
This order was chosen based on the hypothesized causal pathways for the three variables. 
When applying multiple imputation methods in the longitudinal setting, repeated 
measurements of time-dependent variables are considered distinct variables and the dataset is often 
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reshaped to wide format113, 14. However, when the number of repeated measurements is large, MI may 
encounter non-convergence due to over-fitting or multicollinearity. This was true for the Kunsberg data, 
so MI on the wide format dataset could not be completed. One suggested alternative approach is to 
perform the MI with the dataset in long format and include an indicator variable for the cluster in the MI 
models14. For this project, three variations on the imputation models were compared: (1) imputation 
models as written above, (2) the above models with an indicator for cluster included in each, and (3) the 
above models with average values of each variable by cluster included in each. Five imputations were 
run for each scenario. 
Results 
Imputation of Individual Probabilities and Weights 
 The methods for filling in gaps in the weights without imputing the data produced varied results. 
Filling in the individual probabilities with the average IP by subject produced a statistically significant 
estimate for the relationship between doser and FEV1 (βA = 0.099, p = 0.025). This estimate indicates an 
increase in FEV1 of about 6% on days after subjects used their medication. The result from filling in the 
IP with randomly generated values was also statistically significant (βA = 0.240, p = 0.024). The estimate 
indicates an increase in FEV1 of about 15% on days after subjects used their medication. Estimates from 
the other methods ranged from -0.004 to 0.197 and were not statistically significant. See Table III.3 for 
estimates, 95% confidence intervals, and approximate percent improvement in FEV1 after treatment for 
each method. The estimates for percent improvement are based on the average FEV1 across all subjects 
and time points. 
Multiple Imputation of Data 
Results for all three MI scenarios were similar. The final estimate for the effect of doser on FEV1 
was consistently small and consistently statistically insignificant. Estimates for the effect of asthma 
symptoms on doser in the weights model were also smaller than the estimate from the available case 
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data. Under imputation scenario (2) the weights model estimated a negative effect of asthma symptoms 
on doser, but the effect was not statistically significant. Table III.3 shows pooled estimates for the effect 
of doser on FEV1 and ranges of estimates for asthma symptoms on doser across the imputations. The 
results suggest there is no significant effect of doser on FEV1, but it is unclear whether the multiple 
imputation method performed is optimal for the structure of the data. 
Table III.3: Estimates for the effect of doser on FEV1 
  Estimate 95% CI Approximate improvement (%) 
LVCF 0.197 (-0.019, 0.413) 11.9 
restart 0.076 (-0.020, 0.171) 4.6 
IP fill (1) 0.099 (0.012, 0.186) 6.0 
IP fill (2) -0.004 (-0.091, 0.083) -0.2 
IP fill (3) -0.004 (-0.093, 0.086) -0.2 
IP fill (4) 0.24 (0.031, 0.449) 14.5 
MI Scenario (1) 0.007 (-0.028, 0.043) 0.4 
MI Scenario (2) 0.014 (-0.036, 0.064) 0.8 
MI Scenario (3) -0.003 (-0.047, 0.042) -0.2 






















 The simulation was conducted using the free statistical software R version 4.0.2 (https://www.R-
project.org/). Nine cases were tested, each one a unique combination of values for n, T, and percent 
missingness. Number of subjects (i = 1,…,n) was either 50 or 500. Number of time points (t = 1,…,T) was 
either 20 or 200. Percent missingness for L, A, and Y, respectively, was 80/30/60 (closely mimicking the 
Kunsberg data), 40/15/30, or 10/10/10. One thousand datasets were simulated for each case. 
 Covariates for the outcome Y included a binary variable for treatment (1=treated, 0=not 
treated), a binary variable for the previous day’s treatment, and a binary time-varying confounder L.  
Each time-varying confounder value, Lt,i, was simulated as follows: 
Lt,i ~ Bernoulli(pt,i), 
where the link function is a logit:  
pt,i = P(Lt,i = 1|βxt,i ) = 
exp (βxt,i)1+ exp (βxt,i) , 
and  
βxt,i = β0 + β1 At-1,i + β2 Lt-1,i + β3 Yt-1,i. 
 
Each treatment value, At-1,i, was simulated as follows: 
At,i ~ Bernoulli(pt,i),   
where the link function is a logit: 
pt,i = P(At,i = 1|αxt,i ) = 
exp (αxt,i)1+ exp (αxt,i),  
and  
αxt,i = α0 + α1 At-1,i + α2 Lt,i. 
 








εt,i ~ N(0, σ2), b0i ~ N(0,  σ2). 
 
Figure IV.1 shows the directed acyclic graph for the simulated data. 
 
Figure IV.1: Directed acyclic graph for the relationships between L, A, and Y 
 
The true coefficient values for these variables were set as β = (0, -0.5, 0.1, -0.3), α = (0, 1, 1), and γ = (2, 
0.5, -0.75, 0.1). Random intercept values for each subject were drawn from a normal distribution with 
mean 0 and variance 1. See Table IV.1 for a summary of the parameter values for all 9 cases. 
Variables for L, A, and Y with some data points missing were created in the dataset by randomly 
deleting data points according to the three missing data schemes described above. Six models were then 
fit to each dataset: two on the L, A, and Y variables with no missing data points (the ‘full’ data), and four 
on the variables with missing data points. The full data were fit using a MSM with IPTW and with a linear 
mixed model adjusting for L as a confounder (the ‘naïve’ model). Four marginal structural models were 
fit on the variables with missing data points: one filled in gaps in the weights by carrying the last weight 
forward, one filled in gaps in the weights by restarting the weights at one each time there was a gap, 
one filled in the individual probabilities randomly and then used the filled IP to create weights, and one 
filled in the IP with the average IP by subject and then used the filled IP to create weights. Any weights 
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greater than 100 were truncated to avoid convergence issues. Empirical standard errors were used to 
create confidence intervals and p-values for each model. 





points (t) % missing L % missing A  % missing Y true value βA 
1 50 20 80 30 60 0.5 
2 50 20 40 15 30 0.5 
3 50 20 10 10 10 0.5 
4 50 200 80 30 60 0.5 
5 50 200 40 15 30 0.5 
6 50 200 10 10 10 0.5 
7 500 20 80 30 60 0.5 
8 500 20 40 15 30 0.5 
9 500 20 10 10 10 0.5 
 
Beta coefficients for the effect of A on Y and 95% confidence intervals (CI) for each model were 
saved and summarized. Percent coverage for each estimated beta coefficient was calculated as the 
proportion of generated 95% CI that included the true beta. Bias in the coefficient estimates was 
calculated by subtracting the true beta value from the estimated beta value for each generated value of 
each coefficient. Type II error was calculated as the proportion of 95% CI that covered 0. In addition to 
the main simulation results, one dataset from each case was selected randomly for multiple imputation. 
Imputation was performed on each dataset using the mean values of each variable by subject as 
described above. 
Results for Main Simulation 
 Mean values of the estimated βA, mean values for bias, mean values for MSE, percent coverage, 
and percent type II error are summarized in Table IV.2. Selected boxplots show the variation in the 
estimated beta coefficients for cases 1, 4, and 7 (see Appendix). 
 As expected, mean bias and type II error tend to decrease and coverage tends to increase for all 
four models on the missing data as the percent of missing data decreases. Type II error is an issue for all 
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methods when the numbers of subjects and time points are smaller and the percent of missing data is 
the highest. 
Across most of the cases, the method of filling in the individual probabilities randomly tends to 
have the highest mean bias and the highest percent type II error. When the number of time points is 20, 
the random IP method also has the lowest coverage and the highest mean squared error (MSE), though 
when the number of time points is 200 the last value carried forward (LVCF) method has low coverage 
and high MSE compared to the other methods. Interestingly, coverage is noticeably lower and MSE 
higher in the model on the full data when the number of time points is 200 compared to when the 
number of time points is 20. The MSM outperforms the naïve model in the cases with 20 time points but 
has greater mean bias and lower percent coverage when the number of time points is 200. 
Table IV.2: Results from main simulation 
 Case 1 
Naïve 























Bias (mean) 0.039 0.025 0.091 0.046 -0.087 0.032 
MSE 0.003 0.003 0.063 0.036 0.102 0.092 
% coverage 84.9 97.5 89.9 93.7 72.8 80.2 
% type II error 0 0 21.1 13.6 38.8 24.9 
Case 2 
Naïve 























Bias (mean) 0.021 0.003 0.021 0.011 -0.054 0.009 
MSE 0.002 0.002 0.011 0.01 0.034 0.016 
% coverage 93.9 97.1 95.5 95.6 83.6 92.1 
% type II error 0 0 0.2 0 17.2 1.7 
Case 3 
Naïve 























Bias (mean) 0.057 0.037 0.047 0.048 0.008 0.044 
MSE 0.005 0.004 0.006 0.006 0.018 0.007 
% coverage 71.6 94.4 93.1 93.6 88.7 93.4 
% type II error 0 0 0 0.1 4.6 0 
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Table IV.2: Results from main simulation (continued) 
Case 4  
Naïve 























Bias (mean) 0.004 -0.009 0.068 -0.059 -0.122 -0.105 
MSE 0 0.001 0.069 0.006 0.023 0.026 
% coverage 94.1 89.7 25.4 77.7 61 67.3 
% type II error 0 0 3.8 0 1.4 7 
Case 5  
Naïve 























Bias (mean) 0 -0.013 -0.009 -0.02 -0.109 -0.054 
MSE 0 0.002 0.009 0.001 0.015 0.013 
% coverage 95.8 86.5 86.1 91.5 44.9 63.2 
% type II error 0 0 0.1 0 0 1 
Case 6 
Naïve 























Bias (mean) 0.002 -0.009 -0.006 -0.003 -0.081 -0.01 
MSE 0 0.002 0.002 0.001 0.009 0.003 
% coverage 94.1 88.2 93.3 95.2 54.1 78.2 
% type II error 0 0 0 0 0 0 
Case 7 
Naïve 























Bias (mean) 0.022 0.006 0.013 -0.014 -0.099 0.006 
MSE 0.001 0 0.005 0.003 0.025 0.024 
% coverage 59.2 97.4 95.8 95.3 80.7 89.3 
% type II error 0 0 0 0 10.4 6.7 
Case 8 
Naïve 























Bias (mean) 0.028 0.011 0.028 0.017 -0.055 0.014 
MSE 0.001 0 0.002 0.001 0.008 0.003 
% coverage 40 94.7 92.6 94.5 83.3 95.3 




























Bias (mean) 0.022 0.005 0.006 0.005 -0.021 0.011 
MSE 0.001 0 0 0 0.003 0.001 
% coverage 58.6 97.2 97.4 97.9 92 96.3 




Figure IV.2: Comparison of percent coverage and MSE for simulation results. Plots in the top row show 
results from cases with the highest percentage of missing data (cases 1, 4, and 7); plots in the middle 
row show results from cases with the mid-range percentage of missing data (cases 2, 5, and 8); and plots 
in the bottom row show results from cases with the lowest percentage of missing data (cases 3, 6, and 
9). Different combinations of number of subjects and time points are shown on the x-axis. 
 
Results for Multiple Imputation on Imputed Data 
 The results for multiple imputation on the simulated data showed a consistent pattern across all 
cases. Analysis of the imputed variables gave estimates for βA that were lower than the estimates for the 
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full data; and the higher the percentage of missingness, the lower the estimate. See results for all nine 
cases in Table IV.3. Unlike the MI performed on the Kunsberg data, the reduced estimates from the 
simulated data remained statistically significant; however, this could be due to a stronger effect of A on 
Y in the simulated data. 
Table IV.3: Multiple Imputation result on simulated datasets 
Case ΒA full data 95% CI full data ΒA imputed data 95% CI imputed data 
% decrease in 
estimate 
1 0.525 (0.401, 0.650) 0.285 (0.177, 0.392) 45.7 
2 0.591 (0.485, 0.697) 0.374 (0.248, 0.500) 36.7 
3 0.539 (0.447, 0.632) 0.454 (0.352, 0.556) 15.8 
4 0.506 (0.423, 0.589) 0.282 (0.197, 0.366) 44.3 
5 0.445 (0.380, 0.510) 0.348 (0.245, 0.451) 21.8 
6 0.491 (0.447, 0.535) 0.440 (0.338, 0.542) 10.4 
7 0.522 (0.489, 0.556) 0.232 (0.182, 0.283) 55.6 
8 0.504 (0.470, 0.538) 0.365 (0.314, 0.415) 27.6 














 The simulation results suggest that filling in the individual probabilities randomly before creating 
the weights is not a good choice for the Kunsberg data due to the variability and bias in the estimates. 
Neither is the multiple imputation method, because of the dramatic decrease in the estimate of the 
effect of interest when the percentage of missing data was high. In the cases with a small number of 
subjects and large number of time points, the LVCF method had poor coverage and more variability in 
the estimates than the random IP method. These results suggest the method of restarting the weights is 
the most adequate of those explored here, as it consistently showed the smallest mean bias and highest 
percent coverage of the models fit on the variables with missing data points. The estimate of the effect 
of doser on FEV1 produced by restarting the weights was not statistically significant (βA = 0.076, p = 
0.122). However, this estimate suggests an increase in FEV1 of about 4.6% on days after subjects used 
their medication, which is a reasonable estimate given results from previous literature12. 
Limitations 
 The above conclusions rest on the assumption that the simulated data reflect the structure of 
the Kunsberg data. We have assumed statistically significant effects of asthma symptoms on medication 
use, medication use on asthma symptoms, asthma symptoms on FEV1, and medication use on FEV1. We 
have also assumed the missingness is ignorable. These assumptions are unverified, and if false may 
invalidate the simulation results. 
The MSM with IPTW approach has several notable advantages and disadvantages. It is easy to 
understand and to implement, and only the final MSM and the models for the weights need to be 
specified. However, the weighting can be unstable and inefficient when there are extreme weights15. In 
cases where extreme weights are present, weight truncation may improve estimation of the marginal 
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treatment effect by increasing coverage and decreasing bias11, but there is currently no set standard for 
weight truncation known to produce optimal results. 
Future Directions 
 Several of the methods for filling in missing weights employed in this project produced extreme 
weight values. In the future it may be useful to experiment with different weight truncation or 
normalization methods to see how the model results are affected. It may also be useful to introduce 
non-ignorable missingness and add an unmeasured confounder to the simulated data, given that our 
assumptions of ignorable missingness and no unmeasured confounding are untestable. Experimenting 
with a wider variety of values for number of subjects and number of time points could help to narrow 
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SELECTED BOXPLOTS FOR SIMULATED ESTIMATES 
 
 






Figure A.2: Distribution of estimates for case 4 
 
 
Figure A.3: Distribution of estimates for case 7 
 
